[HTML][HTML] A review on recent drug delivery systems for posterior segment of eye
K Nayak, M Misra - Biomedicine & pharmacotherapy, 2018 - Elsevier
Eye is the unique sense organ with complex and sophisticated anatomy and physiology.
Being most instrumental for vision, it is secured by varied protective barriers; ranging from …
Being most instrumental for vision, it is secured by varied protective barriers; ranging from …
Engineering siRNA therapeutics: challenges and strategies
Small interfering RNA (siRNA) is a potential method of gene silencing to target specific
genes. Although the US Food and Drug Administration (FDA) has approved multiple siRNA …
genes. Although the US Food and Drug Administration (FDA) has approved multiple siRNA …
Journey of siRNA: clinical developments and targeted delivery
RR Nikam, KR Gore - Nucleic acid therapeutics, 2018 - liebertpub.com
Since the evolutionary discovery of RNA interference and its utilization for gene knockdown
in mammalian cell, a remarkable progress has been achieved in small interfering RNA …
in mammalian cell, a remarkable progress has been achieved in small interfering RNA …
Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: Progress towards non-viral systems
A Hakim, B Guido, L Narsineni, DW Chen… - Advanced drug delivery …, 2023 - Elsevier
Glaucoma is the result of the gradual death of retinal ganglion cells (RGCs) whose axons
form the optic nerve. Elevated intraocular pressure (IOP) is a major risk factor that …
form the optic nerve. Elevated intraocular pressure (IOP) is a major risk factor that …
Diatom silica for biomedical applications: recent progress and advances
Diatoms are unicellular photosynthetic algae enclosed in porous 3D nanopatterned silica
enclosures called “frustules.” The diatom frustules are made from biosilica self‐assembled …
enclosures called “frustules.” The diatom frustules are made from biosilica self‐assembled …
Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments
Y Wang, DW Grainger - Advanced drug delivery reviews, 2019 - Elsevier
Given the successful entry of several liposomal drug products into market, and some with
decades of clinical efficacy, liposomal drug delivery systems have proven capabilities to …
decades of clinical efficacy, liposomal drug delivery systems have proven capabilities to …
[HTML][HTML] Co-delivery of miR-181a and melphalan by lipid nanoparticles for treatment of seeded retinoblastoma
SN Tabatabaei, RM Derbali, C Yang… - Journal of Controlled …, 2019 - Elsevier
Melphalan is an efficient chemotherapeutic agent that is currently used to treat
retinoblastoma (Rb); however, the inherent risk of immunogenicity and the hazardous …
retinoblastoma (Rb); however, the inherent risk of immunogenicity and the hazardous …
Novel therapies for the prevention of fibrosis in glaucoma filtration surgery
Conjunctival fibrosis remains the major impediment to the success of glaucoma filtration
surgery. Anti-metabolites remain the gold standard for mitigating post-surgical fibrosis, but …
surgery. Anti-metabolites remain the gold standard for mitigating post-surgical fibrosis, but …
Liposome-targeted delivery for highly potent drugs
H Bardania, S Tarvirdipour… - … cells, nanomedicine, and …, 2017 - Taylor & Francis
Considerable adverse side effects and cytotoxicity of highly potent drugs for healthy tissue
require the development of novel drug delivery systems to improve pharmacokinetics and …
require the development of novel drug delivery systems to improve pharmacokinetics and …
[HTML][HTML] Serum response factor (SRF) promotes ROS generation and hepatic stellate cell activation by epigenetically stimulating NCF1/2 transcription
Activation of hepatic stellate cells (HSC) is a hallmark event in liver fibrosis. Accumulation of
reactive oxygen species (ROS) serves as a driving force for HSC activation. The regulatory …
reactive oxygen species (ROS) serves as a driving force for HSC activation. The regulatory …